Zhitong Finance App News, Times Angel (06699) issued an announcement. On September 11, 2026, the board of directors of the Company decided to grant a total of 1,563,900 restricted share units to 16 grantees (grantees) in accordance with the restricted share unit plan after the initial public offering.
Among them, three executive directors, namely Mr. Feng (Executive Director and Chairman of the Board), Mr. Hu (Executive Director, Chief Executive Officer and Chief Technology Officer), and Mr. Huang (Executive Director and President of Global Business (excluding Mainland China)), were granted a total of 1,255,800 restricted share units (restricted share units granted for a period of three years). The award is a one-time three-year retroactive award to recognize their past contributions and achievements. In addition, 13 other employees of the Company were granted a total of 308,126 restricted share units (other restricted share unit grants, together with the three-year restricted share unit award, the “restricted share unit grant”). The award of a restricted share unit for a period of three years is subject to approval by independent shareholders at a special shareholders' meeting and acceptance by selected directors and grantees before it can be realized.
The Group achieved strong performance in the first half of 2026. Revenue and net profit increased by 42.9% and 79.6% respectively over the same period in 2025. The Group formulated its first three-year globalization plan in 2022. With the growth momentum formed thereafter, the Group's global business (excluding mainland China) reached a major milestone during the reporting period: the number of cases and revenue each accounted for more than half of the Group's total number of invisible correction cases and total revenue, and achieved profits ahead of schedule. The Board of Directors believes that the speed and scale of the Group's global transformation is particularly remarkable. This is not simply geographical expansion; it requires the Group to make fundamental changes in people, capabilities, culture and operating model to become a more global enterprise. Growing from a domestic business to a global enterprise requires winning the trust of new customers, adapting to different clinical practices and market environments, attracting and empowering international talent, and dealing with complex regulatory and operational requirements in multiple jurisdictions.
The restricted share unit is awarded in recognition of the Group's management team's contribution to the Group's business development and globalization. In particular, when considering granting restricted share units for a period of three years to each of the selected directors' successors, the Board of Directors and the Remuneration Committee noted that although the selected directors' successors played an important role in formulating and implementing the Group's globalization strategy and business development initiatives, they did not receive any equity incentives in the Company. Therefore, the award of a three-year restricted share unit is a one-time three-year retroactive award. The purpose is to recognize the past contributions of selected directors and grantors, and only after the Group has achieved and exceeded the main milestones set by its initial three-year globalization plan.